The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients.

PubWeight™: 1.58‹?› | Rank: Top 4%

🔗 View Article (PMID 12547051)

Published in J Pain Symptom Manage on November 01, 2002

Authors

Pål Klepstad1, Jon Håvard Loge, Petter C Borchgrevink, Tito R Mendoza, Charles S Cleeland, Stein Kaasa

Author Affiliations

1: Department of Anesthesiology and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.

Articles citing this

Development of a PROMIS item bank to measure pain interference. Pain (2010) 2.85

A cross-sectional study on prevalence of pain and breakthrough pain among an unselected group of outpatients in a tertiary cancer clinic. Support Care Cancer (2014) 1.97

Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain (2006) 1.72

Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain. Mol Pain (2008) 1.41

The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations. Pain Med (2010) 1.40

Cutpoints for mild, moderate and severe pain in patients with osteoarthritis of the hip or knee ready for joint replacement surgery. BMC Musculoskelet Disord (2008) 1.26

Validation of brief pain inventory to Brazilian patients with pain. Support Care Cancer (2010) 0.98

Psychometric properties of the Brief Pain Inventory among patients with osteoarthritis undergoing total hip replacement surgery. Health Qual Life Outcomes (2010) 0.95

Association between hope and burden reported by family caregivers of patients with advanced cancer. Support Care Cancer (2013) 0.94

Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI). J Pain Symptom Manage (2010) 0.94

Functional interference clusters in cancer patients with bone metastases: a secondary analysis of RTOG 9714. Int J Radiat Oncol Biol Phys (2009) 0.93

Comparison of pain response and functional interference outcomes between spinal and non-spinal bone metastases treated with palliative radiotherapy. Support Care Cancer (2011) 0.92

Utilization of brief pain inventory as an assessment tool for pain in patients with cancer: a focused review. Indian J Palliat Care (2011) 0.89

Calcium, parathyroid hormone, and vitamin D: major determinants of chronic pain in hemodialysis patients. Clin J Am Soc Nephrol (2009) 0.87

Occupational rehabilitation programs for musculoskeletal pain and common mental health disorders: study protocol of a randomized controlled trial. BMC Public Health (2014) 0.86

Patients´ experiences of pain following day surgery - at 48 hours, seven days and three months. Open Nurs J (2011) 0.84

Preoperative pain catastrophizing and postoperative pain after total knee arthroplasty: a prospective cohort study with one year follow-up. BMC Musculoskelet Disord (2016) 0.84

Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression. Trials (2009) 0.81

Cancer pain management at home (I): do older patients experience less effective management than younger patients? Support Care Cancer (2008) 0.81

Pain and pressure pain thresholds in adolescents with chronic fatigue syndrome and healthy controls: a cross-sectional study. BMJ Open (2014) 0.81

Preoperative Pain, Symptoms, and Psychological Factors related to Higher Acute Pain Trajectories during Hospitalization for Total Knee Arthroplasty. PLoS One (2016) 0.80

Analgesia and central side-effects: two separate dimensions of morphine response. Br J Clin Pharmacol (2013) 0.80

Measurement of affective and activity pain interference using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903. Pain Med (2012) 0.80

Validation of symptom clusters in patients with metastatic bone pain. Curr Oncol (2008) 0.79

A particular effect of sleep, but not pain or depression, on the blood-oxygen-level dependent response during working memory tasks in patients with chronic pain. J Pain Res (2015) 0.78

Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain. Eur J Clin Pharmacol (2012) 0.78

Validity, Reliability, and Responsiveness of the Brief Pain Inventory in Inflammatory Bowel Disease. Can J Gastroenterol Hepatol (2016) 0.77

Factors that can predict pain with walking, 12 months after total knee arthroplasty. Acta Orthop (2016) 0.77

Hyperbaric oxygen therapy for late radiation tissue injury in gynaecological patients. Support Care Cancer (2009) 0.77

Can cancer patients assess the influence of pain on functions? A randomised, controlled study of the pain interference items in the Brief Pain Inventory. BMC Palliat Care (2007) 0.76

Patients with chronic pain lack somatic markers during decision-making. J Pain Res (2014) 0.75

Patterns of pain and functional improvement in patients with bone metastases after conventional external beam radiotherapy and a telephone validation study. Pain Res Treat (2011) 0.75

Effectiveness of Working Memory Training among Subjects Currently on Sick Leave Due to Complex Symptoms. Front Psychol (2017) 0.75

Relationship between self-reported pain sensitivity and pain after total knee arthroplasty: a prospective study of 71 patients 8 weeks after a standardized fast-track program. J Pain Res (2016) 0.75

A behavioral medicine intervention for community-dwelling older adults with chronic musculoskeletal pain: protocol for a randomized controlled trial. J Pain Res (2017) 0.75

Expectations, effect and experiences of an easily accessible self-management intervention for people with chronic pain: study protocol for a randomised controlled trial with embedded qualitative study. Trials (2016) 0.75

The WE-Study: does botulinum toxin A make walking easier in children with cerebral palsy?: Study protocol for a randomized controlled trial. Trials (2017) 0.75

Post-thoracotomy pain syndrome and sensory disturbances following thoracotomy at 6- and 12-month follow-ups. J Pain Res (2017) 0.75

Confirmatory factor analysis of brief pain inventory (BPI) functional interference clusters in patients with bone metastases. J Pain Manag (2010) 0.75

Impact of marital status and comorbid disorders on health-related quality of life after cardiac surgery. Qual Life Res (2017) 0.75

A multicenter study of attitudinal barriers to cancer pain management. Support Care Cancer (2017) 0.75

Quality of life and symptoms in patients with malignant diseases admitted to a comprehensive cancer centre. Support Care Cancer (2014) 0.75

Articles by these authors

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain (2007) 8.89

Definition and classification of cancer cachexia: an international consensus. Lancet Oncol (2011) 7.78

Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain (2004) 4.72

Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst (2005) 4.51

Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res (2004) 4.33

Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol (2012) 3.65

Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage (2011) 3.44

Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol (2012) 3.26

The extent of neurocognitive dysfunction in a multidisciplinary pain centre population. Is there a relation between reported and tested neuropsychological functioning? Pain (2013) 2.80

Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol (2005) 2.76

Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol (2011) 2.70

Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up. J Clin Oncol (2002) 2.65

Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain (2007) 2.47

Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors. Cancer (2011) 2.18

The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors. Palliat Med (2003) 2.18

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer (2002) 2.17

Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Clin J Pain (2007) 2.07

Which domains should be included in a cancer pain classification system? Analyses of longitudinal data. Pain (2012) 2.07

Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer (2002) 2.01

The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain (2005) 2.00

Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manage (2012) 1.97

Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf) (2002) 1.97

The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer (2005) 1.97

A cross-sectional study on prevalence of pain and breakthrough pain among an unselected group of outpatients in a tertiary cancer clinic. Support Care Cancer (2014) 1.97

Tidsskr Nor Laegeforen (2016) 1.94

Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol (2009) 1.93

Estimating the prevalence of chronic pain: validation of recall against longitudinal reporting (the HUNT pain study). Pain (2012) 1.92

The effect of a physical exercise program in palliative care: A phase II study. J Pain Symptom Manage (2006) 1.92

Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care. J Pain Symptom Manage (2002) 1.91

Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. Lancet Oncol (2012) 1.90

A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation (2004) 1.87

Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial. J Clin Oncol (2004) 1.85

Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain (2010) 1.84

Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials. Pain (2008) 1.82

Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network. Palliat Med (2005) 1.75

Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain (2006) 1.72

Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine (2004) 1.70

Assessment and classification of cancer breakthrough pain: a systematic literature review. Pain (2010) 1.70

Associations between recreational exercise and chronic pain in the general population: evidence from the HUNT 3 study. Pain (2011) 1.70

Patient training in cancer pain management using integrated print and video materials: a multisite randomized controlled trial. Pain (2008) 1.69

Authors' reply to Tendas et al. J Pain Symptom Manage (2013) 1.66

A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. J Palliat Med (2010) 1.64

Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck (2007) 1.63

Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. J Clin Oncol (2013) 1.62

Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study. J Clin Oncol (2011) 1.61

Pain assessment tools: is the content appropriate for use in palliative care? J Pain Symptom Manage (2006) 1.61

Which patients with cancer die at home? A study of six European countries using death certificate data. J Clin Oncol (2010) 1.58

Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun (2010) 1.58

Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401. J Clin Oncol (2003) 1.53

Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen). Lung Cancer (2004) 1.53

Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer (2014) 1.53

Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol (2006) 1.52

Psychosocial effects of cancer cachexia: a systematic literature search and qualitative analysis. J Pain Symptom Manage (2012) 1.50

Non-steroidal anti-inflammatory treatment in cancer cachexia: a systematic literature review. Acta Oncol (2012) 1.49

Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain (2006) 1.48

Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage (2003) 1.47

The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up. Lung Cancer (2003) 1.47

The role of statins in cancer therapy. Oncologist (2006) 1.46

Patient-reported outcomes: instrument development and selection issues. Value Health (2007) 1.46

Update on cancer pain guidelines. J Pain Symptom Manage (2009) 1.46

Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer (2002) 1.46

Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer (2008) 1.43

Japanese version of the MD Anderson Symptom Inventory: a validation study. J Pain Symptom Manage (2003) 1.42

Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain. Mol Pain (2008) 1.41

Reimbursement of analgesics for chronic pain. Tidsskr Nor Laegeforen (2012) 1.41

Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol (2011) 1.41

The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations. Pain Med (2010) 1.40

[Does use of alternative medicine aggravate the survival prognosis in cancer?]. Tidsskr Nor Laegeforen (2003) 1.40

Translational approaches to treatment-induced symptoms in cancer patients. Nat Rev Clin Oncol (2012) 1.38

Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes (2010) 1.34

Pain in aging community-dwelling adults in the United States: non-Hispanic whites, non-Hispanic blacks, and Hispanics. J Pain (2006) 1.33

Reduced mortality in treating acutely sick, frail older patients in a geriatric evaluation and management unit. A prospective randomized trial. J Am Geriatr Soc (2002) 1.33

Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer (2004) 1.32

Using death certificate data to study place of death in 9 European countries: opportunities and weaknesses. BMC Public Health (2007) 1.31

Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behav Immun (2012) 1.31

The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer (2013) 1.30

Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist (2011) 1.30

[Validation of the Spanish version of the Brief Pain Inventory in patients with oncological pain]. Med Clin (Barc) (2003) 1.26

Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage (2006) 1.25

Assessment and classification of cancer pain. Curr Opin Support Palliat Care (2009) 1.25

Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory. Oncology (2004) 1.25

Methodological and structural challenges in palliative care research: how have we fared in the last decades? Palliat Med (2006) 1.24